# Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation

> **NCT05115214** · NA · RECRUITING · sponsor: **Medtronic Cardiac Ablation Solutions** · enrollment: 150 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** SpherePVI™ Catheter

## Key facts

- **NCT ID:** NCT05115214
- **Lead sponsor:** Medtronic Cardiac Ablation Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-19
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-10-15
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05115214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05115214, "Safety and Performance of the Affera SpherePVI™ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05115214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*